Brain Imaging Study on Biomarkers for Chronic Back Pain

NAEnrolling by invitationINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2035

Conditions
Back Pain
Interventions
OTHER

Placebos

Positive treatment expectations will be induced by giving participants capsules containing inert material and telling them that the capsules contain an effective drug that has been approved for treating Chronic Back Pain. They will be requested to take two capsules twice a day and report their pain on paper forms organized as a calendar.

OTHER

Waitlist

These Chronic Back Pain participants will not be given any placebos and will be requested to report their pain on paper forms organized as a calendar.

OTHER

Healthy Controls

Healthy control participants will not receive a placebo drug or be put on a waitlist.

Trial Locations (1)

B3H1V7

Nova Scotia Health Authoity QEII, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER